Japan Reports Modest, But Positive Effect Of Generic-Drug Emphasis
This article was originally published in PharmAsia News
Executive Summary
In Japan, where an emphasis on buying generic drugs began in April 2008, the class of medicine comprised 7.2 percent of spending on prescription drugs. The increase, however, was only a 0.4 percent increase of 2007, the Ministry of Health, Labor and Welfare said. The ministry said the figures indicate the proportion of generics usage is still low, but that at least the change in policy has had an effect. Generics use amounted to 21.1 percent of drugs dispensed for treating blood and other bodily fluid problems in hospital settings. (Click here for more - a subscription may be required
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.